Diabetes News

In a phase 2, double-blind, dose-ranging study, baricitinib showed potential as a Janus kinases 1 and 2 inhibitor, reducing albuminuria in patients with type 2 diabetes and kidney disease, according to a report published in Nephrology Dialysis Transplantation.

Patients with non-proteinuric diabetes mellitus and chronic kidney disease are not at greater risk for cardiorenal syndrome compared to patients with CKD and no diabetes, according to a study published in Nephrology Dialysis Transplantation. The presence of diabetes per se, as well as moderate proteinuria, was associated with a higher mortality and cardiovascular event risk; but abnormal proteinuria effected the risk of ESRD independent of diabetes.

Insured, adult patients with type 2 diabetes that received sulfonylureas or basal insulin as a second-line antidiabetic medication therapy were at increased risk for certain CV events, according to findings recently published in JAMA Network Open.

Women with active migraine were at lower risk for type 2 diabetes, according to findings recently published in JAMA Neurology.

More than half of patients with type 2 diabetes being managed with treatments other than insulin who filled three or more claims for test strips may have used those supplies inappropriately, according to a report recently published in JAMA Internal Medicine.

Insufficient vitamin D levels were linked to earlier death in older men living in Thailand, according to findings published in Geriatrics and Gerontology International.

CHICAGO — The DECLARE-TIMI 58 trial of dapagliflozin in patients with type 2 diabetes who had or were at high risk for atherosclerotic CVD adds to the growing body of evidence demonstrating the favorable effects of SGLT2 inhibitors on CV risk.

Children with poor aerobic fitness in relationship to their total body mass had significantly higher risk for developing risk factors tied to type 2 diabetes and cardiovascular disease than their counterparts who had better aerobic fitness, according to findings recently published in the Scandinavian Journal of Medicine & Science in Sports.

Women with diabetes were 30% more likely than men to not take their medications because of costs, according to findings recently published in the Journal of the American Board of Family Medicine.

SAN DIEGO — Bexagliflozin was effective and well-tolerated in lowering hemoglobin A1c in patients with diabetes and stage 3a/3b CKD, according to study results presented at ASN Kidney Week.